Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 Akedo Akedo +48.58%
#3 DOVU DOVU +47.59%
#4 Velvet Velvet +38.22%
#5 Black Phoenix Black Phoenix +34.27%
#6 Cross Cross +19.42%
#7 DoubleZero DoubleZero +17.37%
#8 Cap Cap +16.79%
#9 Tutorial Tutorial +15.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.89%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Classificação em ações #33956
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Preço da ação
$17.15
Última sincronização: 2026-08-03
Valor de mercado
$6.51M
Variação (1 dia)
9.80%
Variação (1 ano)
289.77%
País
US
Negociar Galera Therapeutics, Inc. (GRTX)

Categoria

Healthcare
Margem Operacional de Galera Therapeutics, Inc. (GRTX)
Margem Operacional em August 2026 TTM: 0.00%
De acordo com os relatórios financeiros mais recentes e o preço das ações da Galera Therapeutics, Inc., a margem operacional atual (TTM) é 0.00%. No final de 2023, a margem operacional era 0.00%.
Histórico da Margem Operacional da Galera Therapeutics, Inc. de 2017 a 2026
Margem Operacional no final de cada ano
Ano Margem Operacional Alterar
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
Margem Operacional de empresas semelhantes ou concorrentes
Empresa Margem Operacional Diferença na Margem Operacional País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -
BE
O que é a Margem Operacional de uma empresa?
A Margem Operacional é um indicador essencial para avaliar a rentabilidade de uma empresa. Margens operacionais mais altas geralmente são melhores, pois mostram que uma empresa consegue vender seus produtos ou serviços por muito mais do que o custo de produzi-los. É calculada dividindo os lucros da empresa pela sua receita.